SILBINOL
SILBINOL, licence 80102121: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- SANUTRA SELECT SILBINOL, SANUTRA SILBINOL
- Licence holder
- Sabinsa Canada Inc.
- NPN or DIN-HM
- 80102121
- Status
- Active licence
- Licence date
- 24 June 2020
- Revision date
- 29 July 2025
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Pterocarpus marsupium Source : Stem heartwood Extract : Matériel brut sec Extraction ratio : 8.0:1.0 Dry plant equivalent : 1800.0 mg Potency : 5.0 % Pterostilbene | 225.0 mg | Not calculated |
Non-medicinal ingredients
farine de riz, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
SOURCE OF ANTIOXIDANT(S)/ PROVIDES ANTIOXIDANT(S). PROVIDES ANTIOXIDANT THAT HELPS FIGHT/ PROTECT (CELL) AGAINST/ REDUCE (OXIDATIVE EFFECT OF/ THE OXIDATIVE DAMAGE CAUSE BY/ CELL CAMAGE CAUSED BY) FREE RADICALS.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80102121
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.